TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography
Recruiting
N/A
Interventional Study
Breast Neoplasm Malignant Primary
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 250 (estimated)
- Sponsor
- Norwegian University of Science and Technology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
TRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer treatment related cardiac dysfunction (CTRCD).
Secondly, the study will evaluate whether novel tools used to improve stand…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Breast cancer and referral for follow-up to identify potential CTRCD
Exclusion Criteria:
* Not willing or able to consent
Contacts